Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.

Publication | Closed Access

DOI

Citations

References

1996

Year

Yosuke Masuda, Tsukasa Sugo, Takao Kikuchi, Akira Kawata, Mioko Satoh, Yutaka Fujisawa, Yoshiki Itoh, Mitsuhiro Wakimasu, Tetsuya Ohtaki

Journal of Pharmacology and Experimental Therapeutics